Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine Intranasal Premedication in Pediatric Surgery
NCT03725930Phase 3Completed
- Sponsor
- CHU de Lille
- Start
- Mar 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anxiety disorder comparing Clonidine with Placebo (2 arms). Primary endpoint: Anxiolysis score at 30 minutes. Started Mar 2019; status: completed.
02
Drugs
clonidine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT03725930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03725930.